POSTED: October 20, 2011

In this NBC Nightly News video, watch UCLA Jonsson Comprehensive Cancer Center researcher Dr. Dennis Slamon discuss a new study that reports that treating women with a combination of chemotherapy and the molecularly targeted drug Herceptin can significantly increase survival in patients with a specific genetic mutation that results in very aggressive disease.